R.V.Metropolis Diagnostic & Health Care Center Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.34 M
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 7.09 M
- Revenue Growth -3.50%
- Profit Growth 15.02%
- Ebitda 5.22%
- Net Worth -40.35%
- Total Assets -14.29%
About R.V.Metropolis Diagnostic & Health Care Center
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
-
Apps
Corporate Identity Details
-
CIN/LLPIN
U85110MH2005PTC355993
-
Company No.
035919
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Mar 2005
-
Date of AGM
10 Aug 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at R.V.Metropolis Diagnostic & Health Care Center?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijender Singh
|
Director | 14-Jun-2017 | Current |
|
Rakesh Agarwal
|
Director | 03-Feb-2020 | Current |
|
Ameera Shah
|
Director | 03-Apr-2008 | Current |
Financial Performance of R.V.Metropolis Diagnostic & Health Care Center.
R.V.Metropolis Diagnostic & Health Care Center Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 3.5% decrease. The company also saw a substantial improvement in profitability, with a 15.02% increase in profit. The company's net worth observed a substantial decline by a decrease of 40.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.V.Metropolis Diagnostic & Health Care Center?
In 2021, R.V.Metropolis Diagnostic & Health Care Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Centre For Digestive And Kidney Diseases (India) Private LimitedRakesh Agarwal is a mutual person
-
Acc LimitedAmeera Shah is a mutual person
-
Torrent Pharmaceuticals LtdAmeera Shah is a mutual person
-
Centralab Healthcare Services Private LimitedAmeera Shah is a mutual person
-
Ekopath Metropolis Lab Services Private LimitedRakesh Agarwal is a mutual person
-
Metropolis Healthcare Limited
Ameera Shah is a mutual person
Charges (Loans)
₹0
₹7.09 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.71 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2007 | Canara Bank | ₹6.63 M | Satisfied |
| 28 Dec 2006 | Canara Bank | ₹0.46 M | Satisfied |
How Many Employees Work at R.V.Metropolis Diagnostic & Health Care Center?
Unlock and access historical data on people associated with R.V.Metropolis Diagnostic & Health Care Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.V.Metropolis Diagnostic & Health Care Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.V.Metropolis Diagnostic & Health Care Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
